Current Practices of Percutaneous Coronary Intervention in Korea between 2011 and 2015.
作者信息
Jeong Han Saem, Hong Soon Jun
机构信息
Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, Korea.
出版信息
Korean Circ J. 2018 Apr;48(4):322-324. doi: 10.4070/kcj.2018.0058.
Abstract
摘要
相似文献
1
Current Practices of Percutaneous Coronary Intervention in Korea between 2011 and 2015.2011年至2015年韩国经皮冠状动脉介入治疗的现状
Korean Circ J. 2018 Apr;48(4):322-324. doi: 10.4070/kcj.2018.0058.
2
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.韩国经皮冠状动脉介入治疗的现状：基于2014年韩国经皮冠状动脉介入治疗（K-PCI）注册研究队列
Korean Circ J. 2017 May;47(3):328-340. doi: 10.4070/kcj.2017.0071. Epub 2017 May 25.
3
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.急性冠状动脉综合征患者经皮冠状动脉介入治疗后 6 个月与 12 个月或更长时间双联抗血小板治疗（SMART-DATE）：一项随机、开放标签、非劣效性试验。
Lancet. 2018 Mar 31;391(10127):1274-1284. doi: 10.1016/S0140-6736(18)30493-8. Epub 2018 Mar 12.
4
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.当前针对三支血管病变及左主干冠状动脉疾病的经皮冠状动脉介入治疗和冠状动脉旁路移植术实践。来自SYNTAX导入期的见解。
Eur J Cardiothorac Surg. 2006 Apr;29(4):486-91. doi: 10.1016/j.ejcts.2006.01.047. Epub 2006 Feb 23.
5
Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.ST段抬高型心肌梗死患者药物介入策略与直接经皮冠状动脉介入治疗的倾向评分匹配分析
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003508.
6
The Practice Pattern of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.韩国经皮冠状动脉介入治疗的实践模式：基于2014年韩国经皮冠状动脉介入治疗（K-PCI）注册研究队列。
Korean Circ J. 2017 May;47(3):320-327. doi: 10.4070/kcj.2017.0070. Epub 2017 May 25.
7
Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes (SMART-DATE) prospective multicenter randomized trial.急性冠状动脉综合征患者经皮冠状动脉介入治疗后6个月双联抗血小板治疗的安全性：智能血管成形术研究团队-急性冠状动脉综合征患者经皮冠状动脉介入治疗后6个月双联抗血小板治疗的安全性（SMART-DATE）前瞻性多中心随机试验的原理与设计
Am Heart J. 2016 Dec;182:1-8. doi: 10.1016/j.ahj.2016.07.022. Epub 2016 Aug 26.
8
The Current Status of Intervention for Intermediate Coronary Stenosis in the Korean Percutaneous Coronary Intervention (K-PCI) Registry.韩国经皮冠状动脉介入治疗（K-PCI）注册研究中冠状动脉中度狭窄的干预现状
Korean Circ J. 2019 Nov;49(11):1022-1032. doi: 10.4070/kcj.2019.0074. Epub 2019 Jun 5.
9
Coronary Computed Tomography Angiography Predicts Guidewire Crossing and Success of Percutaneous Intervention for Chronic Total Occlusion: Korean Multicenter CTO CT Registry Score as a Tool for Assessing Difficulty in Chronic Total Occlusion Percutaneous Coronary Intervention.冠状动脉计算机断层扫描血管造影术预测慢性完全闭塞病变经皮介入治疗的导丝通过情况及成功率：韩国多中心慢性完全闭塞病变CT注册研究评分作为评估慢性完全闭塞病变经皮冠状动脉介入治疗难度的工具
Circ Cardiovasc Imaging. 2017 Apr;10(4). doi: 10.1161/CIRCIMAGING.116.005800.
10
Erratum: The Practice Pattern of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.勘误：韩国经皮冠状动脉介入治疗的实践模式：基于2014年韩国经皮冠状动脉介入治疗（K-PCI）注册研究队列。
Korean Circ J. 2017 Jul;47(4):541. doi: 10.4070/kcj.2016.0446. Epub 2017 Jun 22.
本文引用的文献
1
Trends, Characteristics, and Clinical Outcomes of Patients Undergoing Percutaneous Coronary Intervention in Korea between 2011 and 2015.2011年至2015年韩国接受经皮冠状动脉介入治疗患者的趋势、特征及临床结局
Korean Circ J. 2018 Apr;48(4):310-321. doi: 10.4070/kcj.2017.0359.
2
Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases.全中心经皮冠状动脉介入治疗量与30天死亡率：一项对427467例择期、紧急和急诊病例的当代全国队列研究。
Circ Cardiovasc Qual Outcomes. 2017 Mar;10(3). doi: 10.1161/CIRCOUTCOMES.116.003186.
3
Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions.COURAGE试验和BARI-2D试验后经皮冠状动脉介入治疗量的趋势：来自超过810万例经皮冠状动脉介入治疗的洞察
Int J Cardiol. 2015 Mar 15;183:6-10. doi: 10.1016/j.ijcard.2015.01.053. Epub 2015 Jan 27.
4
Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry.经皮冠状动脉介入治疗患者急性肾损伤的当代验证风险模型：来自国家心血管数据注册中心导管介入治疗注册库的见解
J Am Heart Assoc. 2014 Dec;3(6):e001380. doi: 10.1161/JAHA.114.001380.
5
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2014年美国心脏病学会/美国心脏协会/美国胸外科医师协会/预防心血管护士协会/心血管造影和介入学会/胸外科医师学会对稳定型缺血性心脏病患者诊断和管理指南的重点更新：美国心脏病学会/美国心脏协会实践指南工作组、美国胸外科医师协会、预防心血管护士协会、心血管造影和介入学会及胸外科医师学会的报告
J Am Coll Cardiol. 2014 Nov 4;64(18):1929-49. doi: 10.1016/j.jacc.2014.07.017. Epub 2014 Jul 28.
6
Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.在 ST 段抬高型心肌梗死患者中，不同药物洗脱支架或金属裸支架的结局：来自随机试验 34068 患者年随访的试验水平数据的混合治疗比较分析。
Circ Cardiovasc Interv. 2013 Aug;6(4):378-90. doi: 10.1161/CIRCINTERVENTIONS.113.000415. Epub 2013 Aug 6.
7
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2012年美国心脏病学会基金会/美国心脏协会（ACCF/AHA）重点更新内容纳入ACCF/AHA 2007年不稳定型心绞痛/非ST段抬高型心肌梗死患者管理指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2013 Jun 11;61(23):e179-347. doi: 10.1016/j.jacc.2013.01.014. Epub 2013 Apr 29.
8
Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.经皮冠状动脉介入治疗与稳定型冠状动脉疾病最佳药物治疗的比较：随机临床试验的系统评价和荟萃分析。
Circ Cardiovasc Interv. 2012 Aug 1;5(4):476-90. doi: 10.1161/CIRCINTERVENTIONS.112.970954. Epub 2012 Aug 7.
9
Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience.经皮冠状动脉介入治疗后住院及长期预后的25年趋势：单机构经验
Circulation. 2007 Jun 5;115(22):2835-41. doi: 10.1161/CIRCULATIONAHA.106.632679. Epub 2007 May 28.
10
Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology.
Eur Heart J. 2006 Dec;27(23):2902-3; author reply 2903. doi: 10.1093/eurheartj/ehl308. Epub 2006 Oct 23.
Zotero 插件